Intravascular tissue factor pathway - A model for rapid initiation of coagulation within the blood vessel

Thrombosis and Haemostasis

Volumn 89, Issue 1, 2003, Pages 3-8

  Engelmann, Bernd ^a   Luther, Thomas ^b   Müller, Ingrid ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Circulating microvesicles; Factor VIIa; Factor Xa; P selectin; PSGL 1

Indexed keywords

BETA3 INTEGRIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; CD11B ANTIGEN; CD18 ANTIGEN; COLLAGEN; FIBRIN; FIBRINOGEN RECEPTOR; LOW DENSITY LIPOPROTEIN; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; SUPEROXIDE DISMUTASE; THROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

APOPTOSIS; ATHEROSCLEROTIC PLAQUE; BIOLOGICAL MODEL; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BLOOD VESSEL; BLOOD VESSEL RUPTURE; CELL GRANULE; GENE ACTIVATION; HEMOSTASIS; HUMAN; LEUKOCYTE AGGREGATION; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REVIEW; RISK FACTOR; THROMBOCYTE; THROMBOCYTE MEMBRANE; THROMBOSIS; THROMBUS;

EID: 12244256753     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613535     Document Type: Review

References (44)

1. Dahlback B. Blood coagulation. Lancet 2000; 355. 1627-32.
2. Morrissey JH. Tissue factor: An enzyme cofactor and a true receptor. Thromb Haemost 2001; 86: 66-74.
3. Kannemeier C, Feussner A, Stohr H.A, Weisse J, Preissner KT, Romisch J. Factor VII and single-chain plasminogen activator-activating protease: Activation and autoactivation of the proenzyme. Eur J Biochem 2001; 268: 3789-96.
4. Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost 2001; 86: 959-72
5. Camerer E, Kolsto AB, Prydz H. Cell biology of tisosue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41
6. Zhang Y, Deng Y, Luther T, Müller M, Ziegler R, Waldherr R, Stern DM, Nawroth PP. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994; 94: 1320-7.
7. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nat Med 1996; 2: 209-15.
8. Osterud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 605-17.
9. Zillmann A, Luther T, Muller I, Kotzsch M, Spannagl M, Kauke T, Oelschlagel U, Zahler S, Engelmann B. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 2001; 281: 603-9.
10. Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S, Kuriyama R, Matsuzawa K, Hasegawa R, Aoki N. Determination of plasma tissue factor antigen and its clinical significance. Br J Haemamtol 1994; 87: 343-7.
11. Fareed J, Callas DD, Hoppensteads D, Bermes EW. Tissue factor antigen levels in various biological fluids. Blood Coagul Fibrinolysis 1995; 6 (Suppl. 1). S32-S36.
12. Zumbach M, Hofmann M, Borcea V, Luther T, Kotzsch M, Muller M, Hergesell O, Andrassy K, Ritz E, Ziegler R, Wahl P, Nawroth PP. Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol 1997; 105: 206-12.
13. Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, Mizuno Y, Oshima S, Saito T, Tsuji I, Kumeda, K, Kamikubo Y, Nakamura S. Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 1997; 134: 253-9.
14. Misumi K, Ogawa H, Yasue H, Soejima H, Suefuji H, Nishiyama K, Takazoe K, Kugiyama K, Tsuji I, Kumeda K, Nakamura S. Comparison of plasma tissue factor levels in unstable and stable angina pectoris. Am J Cardiol 1998; 81: 22-6.
15. Müller, I, Klocke, A, Alex M, Kotzsch M, Luther T, Morgenstern E, Zieseniss S, Zahler S, Preissner K, Engelmann B. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J (in press).
16. Neuenschwander PF, Morrissey JH. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. J Biol Chem 1992; 267: 14477-82.
17. Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: Another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
18. Osterud B. The role of platelets in decrypting monocyte tissue factor. Semin Hematol 2001; 38 (4 Suppl 12): 2-5.
19. Hoffman M, Monroe DM III. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-65.
20. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000; 96: 170-5.
21. Ott I, Andrassy M, Zieglgansberger D, Geith S, Schomig A, Neumann FJ. Regulation of monocyte procoagulant activity in acute myocardial infarction: Role of tissue factor and tissue factor pathway inhibitor-1. Blood 2001; 97: 3721-6.
22. Siddiqui FA, Desai H, Amirkhosravi A, Amaya M, Francis JL. The presence and release of tissue factor from human platelets. Platelets 2002; 13: 247-53.
23. Berckmans RJ, Nieuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639-46.
24. McEver RP. Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation. Thromb Haemost 2001; 86: 746-56.
25. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated by in vivo by P-selectin on adherent platelets. Nature 1998; 359: 848-51.
26. Kirchhofer D, Sakariassen KS, Clozel M, Tschopp TB, Hadvary P, Nemerson Y, Baumgartner HR. Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood 1993; 81: 2050-8.
27. Goel MS, Diamond SL. Neutrophil enhancement of fibrin deposition under flow through platelet-dependent and -independent mechanisms. Arterioscler Throm Vasc Biol 2001; 21: 2093-8.
28. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104: 1533-7.
29. Cerletti C, Evangelista V, De Gaetano G. P-selectin-beta 2-integrin cross-talk: A molecular mechanism foro polymorphonuclear leukocyte recruitment at the site of vascular damage. Thromb Haemost 1999; 82: 787-93.
30. Weber C, Springer TA. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interfaction of Mac-1 with firinogen bound to alphaIIbbeta3 and stimulated by platelet-activating factor. J Clin Invest 1997; 100: 2085-93.
31. Simon DI, Chen Z, Xu H, et al. Platelet glyco-protein Ib is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000; 192: 193-204.
32. Santoso S, Sachs UJ, Kroll H, Linder M, Ruf A, Preissner KT, Chavakis T. The junctional adhesion molecule 3 (JAM-3) on human platelet is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 2002; 196: 679-91.
33. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 41-3.
34. Vidal C, Spaulding C, Picard F, Schaison F, Melle J, Weber S, Fontenay-Roupie M. Flow cytometry detection of platelet procoagulation activity and microparticles in patients with unstable angina treated by percutaneous coronary angioplasty and stent implantation. Thromb Haemost 2001; 86: 784-90.
35. Evangelista V, Rajtar G, De Gaetano G, White JG, Cerletti C. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: The activity of cathepsin G is not prevented by antiproteinases. Blood 1991; 77: 2379-88.
36. Clark RA, Klebanoff SJ. Neutrophil-platelet interaction mediated by myeloperoxidase and hydrogen peroxide. J Immunol 1980; 124: 399-405.
37. Tsuji T, Nagata K, Koike J, Todoroki N, Irimura T. Induction of superoxide anion production from monocytes and neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction. J Leukoc Biol 1994; 56: 583-7.
38. Lesnik P, Dentan C, Vonica A, Moreau M, Chapman MJ. Tissue factor pathway inhibitor activity associated with LDL is inactivated by cell- and copper-mediated oxidation. Arterioscler Thromb Vasc Biol 1995; 15: 1121-30.
39. Novotny WF, Girard TJ, Miletich JP, Broze GJ Jr. Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor. Blood 1988; 72: 2020-5.
40. Libby P. Changing concepts of atherogenesis. J Intern Med 2000; 247: 349-58.
41. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: A role for apoptosis in plaque: A role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-53.
42. Zieseniss S, Zahler S, Muller I, Hermetter A, Engelmann B. Modified phosphatidylethanolamine as the active component of oxidized low density lipoprotein promoting platelet prothrombinase activity. J Biol Chem 2001; 276: 19828-35.
43. Siess W. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-2-phosphate. Biochim Biophys Acta 2002; 1582: 204-15.
44. Lawson CA, Yan SD, Yan SF, Liao H, Zhou YS, Sobel J, Kisiel W, Stern DM, Pinsky DJ. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest 1997; 99: 1729-38.